Vital Sign Monitor Device Validation - WARD (ViVa-WARD)
Status
Conditions
Treatments
Details and patient eligibility
About
Aim: to assess the validity of CE/FDA approved vital sign monitor devices for clinical use in clinical setting.
Patients: up to 1000 medical and/or surgical patients will be included Intervention: Studies with various wirless or novel vital sign monitor devices control: Golden standard measurements or clinical standard devices Outcome: Agreement assessed by bias and limits of agreement between Intervention and control device.
Full description
Aim: to assess the validity of CE/FDA approved vital sign monitor devices for clinical use in clinical setting.
Patients: up to 1000 medical and/or surgical patients will be included. Intervention: Studies with various wireless or novel vital sign monitor devices control: Golden standard measurements or clinical standard devices Outcome: Agreement assessed by bias and limits of agreement between Intervention and control device. Other statistical assessments of agreement may be chosen as secondary outcomes, dependent on the data-structure
Setting: the study will be carried out in up to 76 hours with collection of vital sign data pre-, intra or postoperatively.
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
No inclusion or exclusion criteria
Trial contacts and locations
Loading...
Central trial contact
Eske K Aasvang, DMSci; Christian S Meyhoff, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal